RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ADAMO V
Collezione AO Cuneo

Items : 6

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. in Scientific reports / Sci Rep. 2021 Jul 2;11(1):13770. doi: 10.1038/s41598-021-92774-z.

2021
AO Cuneo

Pizzuti L; Barba M; Mazzotta M; Krasniqi E; Maugeri-Saccà M; Gamucci T; Berardi R; Livi L; Ficorella C; Natoli C; Cortesi E; Generali D; La Verde N; Cassano A; Bria E; Moscetti L; Michelotti A; Adamo V; Zamagni C; Tonini G; Sergi D; Marinelli D; Paoletti G; Tomao S; Botticelli A; Marchetti P; Tinari N; Grassadonia A; Valerio MR; et alii...

Prospective, randomised, multicentre, open-label trial, designed to evaluate the best timing of closure of the temporary ileostomy (early versus late) in patients who underwent rectal cancer resection and with indication for adjuvant chemotherapy: the STOMAD (STOMa closure before or after ADjuvant therapy) randomised controlled trial. in BMJ open / BMJ Open. 2021 Feb 19;11(2):e044692. doi: 10.1136/bmjopen-2020-044692.

2021
ASL Asti
AO Cuneo
ASL Alessandria
ASL Cuneo 1
ASL Torino 3
ASL Torino 4
ASL Vercelli
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Gibin E; Mellano A; Trapani R; Battafarano F; De Rosa C; Giaminardi E; Colli F; Bellora P; Mazza L; Serventi A; Cravero F; Piscioneri D; Adamo V; Rimonda R; Brunetti M; Potente F; Carrera M; Birolo S; Calabrò M; Pipitone N; Panier Suffat L; Tomaselli F; Reddavid R; Santarelli M; Mistrangelo M; Ponte E; Racca P; Monagheddu C; Saccona F; et alii...

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2020 Dec 10;39(1):279. doi: 10.1186/s13046-020-01797-3.

2020
AO Cuneo

Del Medico P; Cazzaniga M; Garufi C; Sarobba G; Giotta F; Paris I; Garrone O; Veltri E; Corsi D; D'Ostilio N; Fabbri MA; Russo A; Mirabelli R; Valerio MR; Marchetti P; Tomao S; Marinelli D; Mazzotta M; Barchiesi G; Zamagni C; Tonini G; Adamo V; Michelotti A; Moscetti L; Bria E; Cassano A; La Verde N; Generali D; Cortesi E; et alii...

State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. in Oncology / Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10.

2014
AO Cuneo

Denaro N; Russi EG; Adamo V; Merlano MC;

The role of antiangiogenic agents in the treatment of head and neck cancer. in Oncology / Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9.

2012
AO Cuneo

Denaro N; Russi EG; Colantonio I; Adamo V; Merlano MC;

The Role of p53 and MDM2 in Head and Neck Cancer. in ISRN otolaryngology / ISRN Otolaryngol. 2011 Dec 7;2011:931813. doi: 10.5402/2011/931813. Print 2011.

2011
AO Cuneo

Denaro N; Lo Nigro C; Natoli G; Russi EG; Adamo V; Merlano MC;